This week's briefing

What happened this week

This week, AI safety shifted from a statement of principle to a question of operating rules: Anthropic opened its practices to outside evaluation, OpenAI took a 2026 IPO off the table, and Washington’s role remained unsettled. At the same time, builders got new agent guidance while deployment, distribution, and capacity decisions kept moving.

Lead story / security risk

Anthropic gives outside reviewers access to its safety work

Anthropic CEO Dario Amodei is calling on frontier AI developers to slow capability gains while putting an immediate oversight mechanism in place at his own company. Anthropic says independent safety evaluators will receive employee-level access, matching the access available to its internal risk-assessment teams.

Those evaluators can examine safety practices and report incidents, and may publish findings without Anthropic’s editorial control. Amodei says the arrangement takes effect immediately, creating a standing review mechanism at Anthropic rather than an industry-wide requirement.

The broader agenda is a request for alignment beyond the company. Amodei proposes permanent independent evaluation across frontier AI companies, common safety standards among democratic countries, and coordination between democratic governments and authoritarian states on shared interests, including a ban on using AI to develop biological weapons.

Amodei’s case for slower progress rests on the possibility that increasingly capable systems could help create their successors, accelerating development faster than people can understand or control it. Anthropic has made its own access commitment; whether slower capability gains and shared standards follow depends on other companies and governments choosing to participate.

business

OpenAI rules out a 2026 IPO over safety concerns

Sam Altman says OpenAI will not pursue an IPO in 2026, calling it an ill-advised moment while safety, alignment, business readiness, and society’s response to more capable AI remain unresolved. He left later timing open. OpenAI has discussed capability pauses and coordination, but announced no measurable readiness test, specific safeguards, or development freeze.

business

Arm CEO says AI could help cure cancer, but current systems fall short

Arm CEO Rene Haas says increasingly capable AI and computing could eventually help cure cancer, but acknowledges that current systems cannot model how the disease affects a DNA marker. The nearer-term evidence is narrower: the NHS says AI-powered X-ray tools helped more than 4 million patients receive faster lung diagnoses earlier this year. Haas also says chip shortages are constraining humanoid-robot deployment.

tools

OpenAI tells developers to use leaner Codex prompts

OpenAI’s guidance for GPT-6 Astra asks teams to trim broad skill descriptions, turn AGENTS.md files into conditional maps, and define exactly what completion means. It retains approval gates for production access, destructive migrations, external effects, and credentials while permitting safe, reversible local work. OpenAI says Astra can stop early when broad workflows lack a clear end state.

government action

Pentagon moves 90% of classified AI work off Anthropic

The Defense Department says roughly 90% of its classified AI workloads have moved away from Anthropic, with the remainder expected to transition by the end of September. The break followed a contract dispute over Anthropic’s proposed restrictions on mass surveillance and fully autonomous lethal weapons. The Pentagon is building a multi-vendor classified AI stack using OpenAI, Google, and xAI while Anthropic’s legal challenge remains pending.

Who tests powerful models, whether competitors can coordinate on safety, and what a voluntary slowdown would require.

The Internet Had a Point

From the timelineOpenAI’s Trojan Horse of Free Models

Reader check-in

Help shape tomorrow's briefing

One click tells us what to keep, improve, or tighten.